EXHIBIT 99.1 Anika Reports Second Quarter 2025 Financial Results Regenerative Solutions revenue up 41% with Integrity Implant System ahead of expectations and continued strong Hyalofast growth; Integrity surpasses full year 2024 performance and is on pace to more than double in 2025 Company released topline results for Hyalofast clinical trial which did not meet pre-specified co-primary end points; Hyalofast demonstrated statistically significant improvements in pre-defined secondary endpoints and other mea ...